Results 11 to 20 of about 11,700 (225)

Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial [PDF]

International Journal of Ophthalmology, 2021
AIM: To evaluate the therapeutic efficacy, safety and tolerability of newly developed preservative-free (PF) latanoprost generic [TJO-002] and compare it with benzalkonium chloride (BAK)-preserved latanoprost [Xalatan®] in patients with primary open ...
Joon Mo Kim, Kyung Rim Sung, Ji Woong Lee, Haksu Kyung, Seungsoo Rho, Chan Yun Kim   +5 more
doaj   +1 more source

Latanoprost eye drops induce conjunctival lymphatic vessel development [PDF]

International Journal of Ophthalmology, 2021
AIM: To investigate the effect of latanoprost eye drops on the conjunctival lymphatics. METHODS: Twenty-four healthy New Zealand White rabbits weighing 1.5 to 2.0 kg were randomly divided into three groups: latanoprost group (n=8) administered with ...
Kai Ma, Qing-Song Li, Cheng-Juan Yin, Zhen-Yong Zhang   +3 more
doaj   +1 more source

Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study

Clinical Ophthalmology, 2018
Mario A Economou,1 Helene Kolstad Laukeland,2,3 Iwona Grabska-Liberek,4 Jean-François Rouland5 1Anterior Segment Department, St Erik’s Eye Hospital, Karolinska Institute, Stockholm, Sweden; 2Department of Ophthalmology, University Hospital,
Economou MA, Laukeland HK, Grabska-Liberek I, Rouland JF   +3 more
doaj   +1 more source

A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of Latanoprost for Eyelash Growth in Aesthetic Medicine

Cosmetics, 2023
Eyelashes, in addition to fulfilling eye-protective functions, generate an aesthetic impact. Latanoprost is a prostaglandin analog, commonly used for the treatment of glaucoma and intraocular hypertension.
Janette Ivone Espinoza-Silva, Ernesto Macias-Nevarez, Christian Quintus Scheckhuber, Mario Adrián Tienda-Vázquez   +3 more
doaj   +1 more source

Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye

International Journal of Nanomedicine, 2012
Jayaganesh V Natarajan1*, Marcus Ang2*, Anastasia Darwitan1, Sujay Chattopadhyay3, Tina T Wong2, Subbu S Venkatraman1 1Materials Science and Engineering, Nanyang Technological University, Singapore; 2Singapore Eye Research Institute, Singapore; 3Polymer ...
Natarajan JV, Ang M, Darwitan A, Chattopadhyay S, Wong TT, Venkatraman SS   +5 more
doaj   +1 more source

24-Hour efficacy of single primary selective laser trabeculoplasty versus latanoprost eye drops for Naïve primary open-angle glaucoma and ocular hypertension patients

Scientific Reports, 2023
This prospective, observer-masked, randomized clinical trial was conducted between December 2018 and June 2021 at Eye Hospital, China Academy of Chinese Medical Sciences. A total of 45 glaucoma patients from Beijing, China, were enrolled in this clinical
Yipeng Shi, Yan Zhang, Wenying Sun, Alex S. Huang, Shuang Chen, Lixia Zhang, Wei Wang, Like Xie, Xiaobin Xie   +8 more
doaj   +1 more source

Analysis of the Responsiveness of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in the Treatment of OAG/OHT Patients

Journal of Ophthalmology, 2021
Aim. Within the clinical setting, some patients have been identified as lacking in response to PGAs. This meta-analysis study aimed to evaluate the responsiveness of latanoprost, travoprost, bimatoprost, and tafluprost in OAG/OHT patients, latanoprost ...
Ziyan Cai, Mengdan Cao, Ke Liu, Xuanchu Duan   +3 more
doaj   +1 more source

Ocular hypotensive efficacy of a new liposomal latanoprost formulation administered by different routes for experimental ocular hypertension

Journal of Ophthalmology, 2022
Background: Prostaglandin analogs (e.g., latanoprost) are the first-line therapy for glaucoma. These medications, however, have a short antihypertensive effect due to low penetration of topical drug across the corneal epithelium, which causes the need ...
I. M. Mikheytseva, G. S. Grygorieva, N. V. Pasyechnikova, S. G. Kolomiichuk, T. I. Siroshtanenko, N. F. Konakhovych   +5 more
doaj   +1 more source

A comparative evaluation of the efficacy and safety of Latanoprost-Optic and Xalatan used as monotherapy and combined with Dorzolamide-Optic for primary open-angle glaucoma under clinical practice conditions

Российский офтальмологический журнал, 2023
The number of ophthalmic antihypertensive drugs available in Russia is steadily increasing, which complicates the choice to be made by ophthalmologist practitioners.
D. P. Novikov, O. A. Frolov, A. S. Pokrovsky, V. V. Novikova   +3 more
doaj   +1 more source

Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma [PDF]

Clinics, 2020
OBJECTIVES: Timolol maleate has been reported to be a safer intraocular pressure (IOP) lowering treatment than latanoprost. The United States Food and Drug Administration approved latanoprostene bunod, a nitric oxide-donating prodrug of latanoprost, for ...
Yulong Wang, Yue Liao, Xin Nie
doaj   +1 more source